-+ 0.00%
-+ 0.00%
-+ 0.00%

LIPELLA PHARMACEUTICALS INC - TO SUBMIT PHASE 2B IND APPLICATION AND BREAKTHROUGH THERAPY REQUEST IN H2 2025

Reuters·02/11/2025 10:46:52

Please log in to view news